{
  "trial_id": "NCT00514046",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Gender, Diagnosis (MEN 2A or MEN 2B), Tumor status (unresectable, recurrent, metastatic), Prior therapy (surgery, radiation, chemotherapy, biological therapy), Performance status (Lansky or Karnofsky score), Hematological function (absolute neutrophil count, platelet count), Coagulation (Prothrombin Time, Partial Thromboplastin Time), Hepatic function (Bilirubin, AST, ALT), Renal function (serum creatinine, creatinine clearance), Thyroid hormone replacement therapy status, Electrolyte levels (potassium, calcium, magnesium), Cardiac history (arrhythmia, QTc interval), Blood pressure, Pregnancy status, Informed consent status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Baseline Performance Status",
          "Performance status (Lansky or Karnofsky score)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Calcitonin (CTN) at Enrollment",
        "Carcinoembryonic Antigen (CEA) at Enrollment"
      ],
      "remaining_candidate_features": [
        "Gender",
        "Diagnosis (MEN 2A or MEN 2B)",
        "Tumor status (unresectable, recurrent, metastatic)",
        "Prior therapy (surgery, radiation, chemotherapy, biological therapy)",
        "Hematological function (absolute neutrophil count, platelet count)",
        "Coagulation (Prothrombin Time, Partial Thromboplastin Time)",
        "Hepatic function (Bilirubin, AST, ALT)",
        "Renal function (serum creatinine, creatinine clearance)",
        "Thyroid hormone replacement therapy status",
        "Electrolyte levels (potassium, calcium, magnesium)",
        "Cardiac history (arrhythmia, QTc interval)",
        "Blood pressure",
        "Pregnancy status",
        "Informed consent status."
      ]
    },
    "processed-gen-response": "Age, Gender, Diagnosis (MEN 2A or MEN 2B), Tumor status (unresectable, recurrent, metastatic), Prior therapy (surgery, radiation, chemotherapy, biological therapy), Performance status (Lansky or Karnofsky score), Hematological function (absolute neutrophil count, platelet count), Coagulation (Prothrombin Time, Partial Thromboplastin Time), Hepatic function (Bilirubin, AST, ALT), Renal function (serum creatinine, creatinine clearance), Thyroid hormone replacement therapy status, Electrolyte levels (potassium, calcium, magnesium), Cardiac history (arrhythmia, QTc interval), Blood pressure, Pregnancy status, Informed consent status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Performance Status, Previous Thyroidectomy, Absolute Neutrophil Count, Platelet Count, Prothrombin Time, Partial Thromboplastin Time, Bilirubin, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Serum Creatinine, Creatinine Clearance, Electrolytes (Potassium, Calcium, Magnesium), Blood Pressure, Cardiac History,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Baseline Performance Status",
          "Performance Status"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Calcitonin (CTN) at Enrollment",
        "Carcinoembryonic Antigen (CEA) at Enrollment"
      ],
      "remaining_candidate_features": [
        "Previous Thyroidectomy",
        "Absolute Neutrophil Count",
        "Platelet Count",
        "Prothrombin Time",
        "Partial Thromboplastin Time",
        "Bilirubin",
        "Aspartate Aminotransferase (AST)",
        "Alanine Aminotransferase (ALT)",
        "Serum Creatinine",
        "Creatinine Clearance",
        "Electrolytes (Potassium, Calcium, Magnesium)",
        "Blood Pressure",
        "Cardiac History"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Performance Status, Previous Thyroidectomy, Absolute Neutrophil Count, Platelet Count, Prothrombin Time, Partial Thromboplastin Time, Bilirubin, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), Serum Creatinine, Creatinine Clearance, Electrolytes (Potassium, Calcium, Magnesium), Blood Pressure, Cardiac History"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Weight, Height, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Heart Rate, Performance Status (Lansky or Karnofsky), Prior Therapy, RET Mutation Status, Calcitonin Levels, Carcinoembryonic Antigen (CEA) Levels, Diarrhea Frequency, Diarrhea Consistency.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Baseline Performance Status",
          "Performance Status (Lansky or Karnofsky)"
        ],
        [
          "Calcitonin (CTN) at Enrollment",
          "Calcitonin Levels"
        ],
        [
          "Carcinoembryonic Antigen (CEA) at Enrollment",
          "Carcinoembryonic Antigen (CEA) Levels"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Weight",
        "Height",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Heart Rate",
        "Prior Therapy",
        "RET Mutation Status",
        "Diarrhea Frequency",
        "Diarrhea Consistency"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Weight, Height, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Heart Rate, Performance Status (Lansky or Karnofsky), Prior Therapy, RET Mutation Status, Calcitonin Levels, Carcinoembryonic Antigen (CEA) Levels, Diarrhea Frequency, Diarrhea Consistency."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, weight, height, Lansky or Karnofsky performance score, serum creatinine, bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), prothrombin time (PT), partial thromboplastin time (PTT), absolute neutrophil count, platelet count, calcitonin, carcinoembryonic antigen (CEA), presence of metastases, prior therapy, presence of diarrhea.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Baseline Performance Status",
          "Lansky or Karnofsky performance score"
        ],
        [
          "Calcitonin (CTN) at Enrollment",
          "calcitonin"
        ],
        [
          "Carcinoembryonic Antigen (CEA) at Enrollment",
          "carcinoembryonic antigen (CEA)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "serum creatinine",
        "bilirubin",
        "aspartate aminotransferase (AST)",
        "alanine aminotransferase (ALT)",
        "prothrombin time (PT)",
        "partial thromboplastin time (PTT)",
        "absolute neutrophil count",
        "platelet count",
        "presence of metastases",
        "prior therapy",
        "presence of diarrhea."
      ]
    },
    "processed-gen-response": "Age, sex, weight, height, Lansky or Karnofsky performance score, serum creatinine, bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), prothrombin time (PT), partial thromboplastin time (PTT), absolute neutrophil count, platelet count, calcitonin, carcinoembryonic antigen (CEA), presence of metastases, prior therapy, presence of diarrhea."
  }
}